These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 2433503

  • 1. Quantitation of platelet preservation with prostanoids during simulated bypass.
    Kappa JR, Musial J, Fisher CA, Addonizio VP.
    J Surg Res; 1987 Jan; 42(1):10-8. PubMed ID: 2433503
    [Abstract] [Full Text] [Related]

  • 2. Iloprost (ZK36374), a stable analogue of prostacyclin, preserves platelets during simulated extracorporeal circulation.
    Addonizio VP, Fisher CA, Jenkin BK, Strauss JF, Musial JF, Edmunds LH.
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):926-33. PubMed ID: 2582210
    [Abstract] [Full Text] [Related]

  • 3. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    Fisher CA, Kappa JR, Sinha AK, Cottrell ED, Reiser HJ, Addonizio VP.
    J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
    [Abstract] [Full Text] [Related]

  • 4. Iloprost and echistatin protect platelets during simulated extracorporeal circulation.
    Bernabei A, Gikakis N, Kowalska MA, Niewiarowski S, Edmunds LH.
    Ann Thorac Surg; 1995 Jan; 59(1):149-53. PubMed ID: 7529485
    [Abstract] [Full Text] [Related]

  • 5. Effects of prostaglandin E1 on platelet loss during in vivo and in vitro extracorporeal circulation with a bubble oxygenator.
    Addonizio VP, Strauss JF, Colman RW, Edmunds LH.
    J Thorac Cardiovasc Surg; 1979 Jan; 77(1):119-26. PubMed ID: 102876
    [Abstract] [Full Text] [Related]

  • 6. Temporary inhibition of platelet function with iloprost (ZK36374) preserves canine platelets during extracorporeal membrane oxygenation.
    Cottrell ED, Kappa JR, Stenach N, Fisher CA, Tuszynski GP, Switalska HI, Addonizio VP.
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):535-41. PubMed ID: 2459560
    [Abstract] [Full Text] [Related]

  • 7. The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor.
    Kondo N, Wakayama F, Suzuki Y, Fukui K, Takaya S, Fukuda I.
    Thromb Res; 2004 Oct; 113(5):303-10. PubMed ID: 15183042
    [Abstract] [Full Text] [Related]

  • 8. Loss of platelet alpha 2-adrenergic receptors during simulated extracorporeal circulation: prevention with prostaglandin E1.
    Wachtogel YT, Musial J, Jenkin B, Niewiarowski S, Edmunds LH, Colman RW.
    J Lab Clin Med; 1985 May; 105(5):601-7. PubMed ID: 4039346
    [Abstract] [Full Text] [Related]

  • 9. Human neutrophil degranulation during extracorporeal circulation.
    Wachtfogel YT, Kucich U, Greenplate J, Gluszko P, Abrams W, Weinbaum G, Wenger RK, Rucinski B, Niewiarowski S, Edmunds LH.
    Blood; 1987 Jan; 69(1):324-30. PubMed ID: 2947645
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT, Kucich U, Hack CE, Gluszko P, Niewiarowski S, Colman RW, Edmunds LH.
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [Abstract] [Full Text] [Related]

  • 12. Effects of prostacyclin and albumin on platelet loss during in vitro simulation of extracorporeal circulation.
    Addonizio VP, Macarak J, Nicolaou KC, Edmunds LH, Colman RW.
    Blood; 1979 Jun; 53(6):1033-42. PubMed ID: 375998
    [No Abstract] [Full Text] [Related]

  • 13. Prostacyclin in lieu of anticoagulation with heparin for extracorporeal circulation.
    Addonizio VP, Fisher CA, Bowen JC, Palatianos GC, Colman RW, Edmunds LH.
    Trans Am Soc Artif Intern Organs; 1981 Jun; 27():304-7. PubMed ID: 7036500
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
    Mardla V, Kobzar G, Samel N.
    Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103
    [Abstract] [Full Text] [Related]

  • 16. Function of human platelets during extracorporeal circulation.
    Hennessy VL, Hicks RE, Niewiarowski S, Edmunds LH, Colman RW.
    Am J Physiol; 1977 Jun; 232(6):H622-8. PubMed ID: 18017
    [Abstract] [Full Text] [Related]

  • 17. Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets.
    Stürzebecher S, Nieuweboer B, Matthes S, Schillinger E.
    Prog Clin Biol Res; 1989 Jun; 301():365-9. PubMed ID: 2477855
    [No Abstract] [Full Text] [Related]

  • 18. Stabilization of standard platelet concentrates and minimization of the platelet storage lesion by a prostacyclin analogue.
    Elias M, Heethuis A, Weggemans M, Bom V, Blom N, McShine RL, Halie MR, Smit Sibinga CT.
    Ann Hematol; 1992 Jun; 64(6):292-8. PubMed ID: 1379080
    [Abstract] [Full Text] [Related]

  • 19. Platelet aggregation: effects of cardiopulmonary bypass.
    Solis RT, Beall AC, Noon GP, DeBakery ME.
    Chest; 1975 May; 67(5):558-63. PubMed ID: 1126194
    [Abstract] [Full Text] [Related]

  • 20. PGI2 and PGE1 induce morphological alterations in human platelets similar to those of the initial phase of activation.
    Zilla P, Groscurth P, Varga G, Fischlein T, Fasol R.
    Exp Hematol; 1987 Aug; 15(7):741-9. PubMed ID: 3301381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.